← Evidence map

ArticleThe Journal of antimicrobial chemotherapy2012

Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.

Eloise Mastrangelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

198 papers cite itlatest 60 shown

2012
…
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 22535622